Ani Pharmaceuticals Inc Liquidation Value

ANIP Other

Cash & Equivalents

$285.58M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $285.58M
Total Obligations: -$581.20M
$-295.62M
Per share: $-13.14
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $285.58M
AR: $281.08M
Total Obligations: -$581.20M
$-14.53M
Per share: $-0.65
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $285.58M
AR: $281.08M
Inventory: $143.07M
Total Obligations: -$581.20M
$128.53M
Per share: $5.71
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-295.62M$-13.14
Liquid Liquidation Value$-14.53M$-0.65
Operating Liquidation Value$128.53M$5.71

Key Components (as of 2025-12-31)

Cash & Equivalents$285.58M
Accounts Receivable$281.08M
Inventory$143.07M
Current Liabilities$278.11M
Long-term Debt$291.84M
Op. Lease Liability$11.10M
Finance Lease$152,000
Shares Outstanding22.5M

Explore all 238 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$285.58M$281.08M$143.07M$62.58M$278.11M$291.84M$11.10M$152,000
2025-09-30$262.61M$252.62M$146.47M$69.80M$270.56M$297.68M$5.20MN/A
2025-08-18N/AN/AN/AN/AN/AN/A$5.20MN/A
2025-06-30$217.80M$225.65M$138.31M$54.57M$236.84M$301.48MN/AN/A
2025-03-31$149.80M$220.33M$137.41M$53.06M$201.81M$305.29MN/AN/A
2024-12-31$144.86M$221.73M$136.78M$45.66M$194.45M$309.11M$6.19M$396,000
2024-09-30$144.98M$196.36M$148.04M$60.89M$189.93M$312.92MN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-27 View
2025-09-30 10-Q 2025-11-07 View
2025-06-30 10-Q 2025-08-08 View
2025-03-31 10-Q 2025-05-09 View
2024-12-31 10-K 2025-02-28 View
2024-09-30 10-Q 2024-11-08 View
2024-06-30 10-Q 2024-08-06 View
2024-03-31 10-Q 2024-05-10 View

Community Notes

Loading notes...

Questions

Loading questions...